Search

Dr Reddy's Laboratories Ltd-ADR

Отворен

СекторЗдравеопазване

11.4 -9.24

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

11.56

Максимум

12.57

Ключови измерители

By Trading Economics

Приходи

-9.7B

2.2B

Продажби

-11B

76B

P/E

Средно за сектора

23.204

62.58

Дивидентна доходност

0.66

Марж на печалбата

2.928

Служители

27,527

EBITDA

-11B

8.8B

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+26.99% upside

Дивиденти

By Acuity

Дивидентна доходност

Средно за сектора

0.66%

2.19%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-537M

10B

Предишно отваряне

20.64

Предишно затваряне

11.4

Настроения в новините

By Acuity

50%

50%

145 / 340 Класиране в Healthcare

Dr Reddy's Laboratories Ltd-ADR Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

21.07.2026 г., 23:51 ч. UTC

News

Regeneron Pharmaceuticals faces a class action lawsuit for securities fraud over misleading claims about Fianlimab-Libtayo trial results. Shares are lower in after-hours trading.

21.07.2026 г., 23:51 ч. UTC

News
Social Media

Pegasystems shares declined in after-market trading following second-quarter results that missed analyst expectations for earnings and revenue, amid concerns over future ACV growth.

21.07.2026 г., 23:46 ч. UTC

News

Adobe Inc. shares are declining in after-market trading following Morgan Stanley's downgrade to "underweight" and a reduced price target of $240.

21.07.2026 г., 23:41 ч. UTC

News

Raytheon Technologies secures a $49.7 million Navy contract for weapon system repairs, with shares trading higher in after-market hours.

21.07.2026 г., 23:41 ч. UTC

Social Media
News

Capital One Financial reported adjusted EPS of $5.81 and revenue of $15.85 billion, exceeding expectations, as shares rose in after-market trading.

21.07.2026 г., 23:41 ч. UTC

Macro News
ETF Constituents
News

Vanguard Information Technology ETF is little changed after market hours, despite broader market gains and negative contributions from Apple, Microsoft, and Nvidia.

21.07.2026 г., 23:36 ч. UTC

News
ETF Constituents

The Vanguard Growth ETF is trading roughly flat in after-market hours, reflecting minor fluctuations among its holdings, including declines from Apple, Microsoft, and Nvidia.

21.07.2026 г., 23:36 ч. UTC

Social Media
News

Micron Technology rose in after-market hours, supported by a semiconductor rally and a Bank of America upgrade to "buy" on strong AI demand.

21.07.2026 г., 23:36 ч. UTC

News

MongoDB shares traded higher after director Dwight Merriman sold 16,000 shares for $5.2 million under a pre-scheduled plan, retaining $496.55 million in holdings.

21.07.2026 г., 23:32 ч. UTC

News

United Community Banks Inc. shares rise in after-market trading after an upgrade to Buy, bolstered by Q2 2026 net interest income of $270.7 million.

21.07.2026 г., 23:26 ч. UTC

Correlated Moves
News

JPMorgan Chase & Co shares showed little change in after-market hours amid broader market movements. CEO Jamie Dimon raised concerns over geopolitical tensions and inflation.

21.07.2026 г., 23:26 ч. UTC

Social Media
Correlated Moves
News

Coinbase Global shares rose in after-market trading amid reports of a regulatory agreement that may benefit digital assets, with Bitcoin approaching $67,000.

21.07.2026 г., 23:26 ч. UTC

News

Lucid Group Inc. faces a class action lawsuit over alleged supplier quality issues, contributing to a decline in after-market trading. Shares earlier stabilized after a session low.

21.07.2026 г., 23:26 ч. UTC

News

Intuit Inc. shares are lower in after-market trading following a class action lawsuit alleging misleading statements about TurboTax revenue growth and competitive advantages.

21.07.2026 г., 23:16 ч. UTC

News

Sprinklr Inc reported first-quarter revenues of $219.5 million, exceeding expectations, but shares are lower in after-market hours amid sector concerns and mixed AI sentiments.

21.07.2026 г., 23:16 ч. UTC

News

Nasdaq shares rise in after-market hours following the dismissal of all claims in the Miami International litigation, positively impacting investor sentiment.

21.07.2026 г., 23:16 ч. UTC

News

Iridium Communications Inc. shares are higher in after-hours trading, reflecting positive market sentiment amid significant gains in technology and semiconductor stocks in Asia.

21.07.2026 г., 23:16 ч. UTC

News

Intel faces valuation scrutiny as modest growth expectations contrast with sector leaders benefiting from AI demand. Shares were roughly flat in after-market hours.

21.07.2026 г., 23:11 ч. UTC

News

Toast Inc shares are trading higher in after-market hours following the announcement of its second quarter 2026 financial results release on August 4.

21.07.2026 г., 23:11 ч. UTC

News

Pfizer Inc. options trading showed light volume, with calls outpacing puts and a put/call ratio of 0.56. Shares were little changed in after-market hours.

21.07.2026 г., 23:06 ч. UTC

News

General Motors plans a new generation of gasoline-powered Cadillac models, shifting from an all-electric strategy. Shares are higher in after-market trading.

21.07.2026 г., 23:02 ч. UTC

News

Park Aerospace shares lower in after-market hours following the unexpected death of Vice President Daniel McNamara, impacting investor sentiment and contributing to the decline.

21.07.2026 г., 23:02 ч. UTC

Event
News

Weatherford International shares advanced in after-market trading following second-quarter results, with revenues of $1.11 billion exceeding expectations despite a decline.

21.07.2026 г., 23:02 ч. UTC

News

Jefferies raised its price target on Genuine Parts Co to $130.00, contributing to after-market gains following a dip earlier in the session.

21.07.2026 г., 23:02 ч. UTC

Event
News
Social Media

AAR Corp shares are lower in after-market trading following mixed fourth-quarter results and cautious guidance, despite exceeding sales and EPS expectations.

21.07.2026 г., 23:02 ч. UTC

News

ServiceNow Inc. shares declined in after-market hours amid concerns about generative AI's impact on the enterprise software sector, according to Morgan Stanley.

21.07.2026 г., 23:01 ч. UTC

News
Social Media

Citigroup Inc declared a quarterly dividend of $0.67 per share, though shares are trading lower after-market amid ongoing market weakness.

21.07.2026 г., 23:01 ч. UTC

News

Norfolk Southern announced a quarterly dividend of $1.35 per share, contributing to shares trading higher in after-market hours following three lower sessions.

21.07.2026 г., 23:01 ч. UTC

News

DigitalOcean shares rise in after-market hours after Baird analyst initiates coverage with an Outperform rating. The stock closed at $119.09 in the prior session.

21.07.2026 г., 23:01 ч. UTC

News
Social Media

Chubb Ltd reported second-quarter net income of $2.85 billion, down from $2.97 billion a year earlier, contributing to lower after-market trading.

Сравнение с други в отрасъла

Ценова промяна

Dr Reddy's Laboratories Ltd-ADR Прогноза

Ценова цел

By TipRanks

26.99% нагоре

12-месечна прогноза

Среден 15.95 USD  26.99%

Висок 15.954 USD

Нисък 15.954 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Dr Reddy's Laboratories Ltd-ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

2 ratings

1

Купи

0

Задържане

1

Продай

Настроение

By Acuity

145 / 340 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Среден

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Dr Reddy's Laboratories Ltd-ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
help-icon Live chat